On-Treatment Grade 3-4 Neutropenia and Clinical Outcomes with Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: ReTrITA Real-World Evidence.

Signorelli C, Basso M, Anghelone A, Calegari MA, Passardi A, Gallio C, Bittoni A, Lucchetti J, Angotti L, Di Giacomo E, Zurlo IV, Morelli C, Dell'Aquila E, Artemi A, Gemma D, Corsi DC, Emiliani A, Ribelli M, Mazzuca F, Arrivi G, Zoratto F, Morandi MG, Santamaria F, Dettori M, Cosimati A, Saltarelli R, Minelli A, Lucci-Cordisco E, Chilelli MG

Open source

DOI
10.32604/or.2026.080964
Published
2026
Container
Oncology research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.32604/or.2026.080964,
  title = {On-Treatment Grade 3-4 Neutropenia and Clinical Outcomes with Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: ReTrITA Real-World Evidence.},
  author = {Signorelli C and Basso M and Anghelone A and Calegari MA and Passardi A and Gallio C and Bittoni A and Lucchetti J and Angotti L and Di Giacomo E and Zurlo IV and Morelli C and Dell'Aquila E and Artemi A and Gemma D and Corsi DC and Emiliani A and Ribelli M and Mazzuca F and Arrivi G and Zoratto F and Morandi MG and Santamaria F and Dettori M and Cosimati A and Saltarelli R and Minelli A and Lucci-Cordisco E and Chilelli MG},
  year = {2026},
  journal = {Oncology research},
  doi = {10.32604/or.2026.080964},
  url = {https://doi.org/10.32604/or.2026.080964}
}

RIS

TY  - JOUR
TI  - On-Treatment Grade 3-4 Neutropenia and Clinical Outcomes with Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: ReTrITA Real-World Evidence.
AU  - Signorelli C
AU  - Basso M
AU  - Anghelone A
AU  - Calegari MA
AU  - Passardi A
AU  - Gallio C
AU  - Bittoni A
AU  - Lucchetti J
AU  - Angotti L
AU  - Di Giacomo E
AU  - Zurlo IV
AU  - Morelli C
AU  - Dell'Aquila E
AU  - Artemi A
AU  - Gemma D
AU  - Corsi DC
AU  - Emiliani A
AU  - Ribelli M
AU  - Mazzuca F
AU  - Arrivi G
AU  - Zoratto F
AU  - Morandi MG
AU  - Santamaria F
AU  - Dettori M
AU  - Cosimati A
AU  - Saltarelli R
AU  - Minelli A
AU  - Lucci-Cordisco E
AU  - Chilelli MG
PY  - 2026
JO  - Oncology research
DO  - 10.32604/or.2026.080964
UR  - https://doi.org/10.32604/or.2026.080964
ER  - 

APA

C, S., M, B., A, A., MA, C., A, P., C, G., A, B., J, L., L, A., E, D. G., IV, Z., C, M., E, D., A, A., D, G., DC, C., A, E., M, R., F, M., G, A., F, Z., MG, M., F, S., M, D., A, C., R, S., A, M., E, L., & MG, C. (2026). On-Treatment Grade 3-4 Neutropenia and Clinical Outcomes with Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: ReTrITA Real-World Evidence.. Oncology research. https://doi.org/10.32604/or.2026.080964

Source records